Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Characterization of hypermutator Pseudomonas aeruginosa isolates from patients with cystic fibrosis in Australia.

Rees VE, Deveson Lucas DS, López-Causapé C, Huang Y, Kotsimbos T, Bulitta JB, Rees MC, Barugahare A, Peleg AY, Nation RL, Oliver A, Boyce JD, Landersdorfer CB.

Antimicrob Agents Chemother. 2019 Feb 11. pii: AAC.02538-18. doi: 10.1128/AAC.02538-18. [Epub ahead of print]

PMID:
30745381
2.

Meropenem Combined with Ciprofloxacin Combats Hypermutable Pseudomonas aeruginosa from Respiratory Infections of Cystic Fibrosis Patients.

Rees VE, Yadav R, Rogers KE, Bulitta JB, Wirth V, Oliver A, Boyce JD, Peleg AY, Nation RL, Landersdorfer CB.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01150-18. doi: 10.1128/AAC.01150-18. Print 2018 Nov.

PMID:
30104278
3.

Identification of Novel Acinetobacter baumannii Type VI Secretion System Antibacterial Effector and Immunity Pairs.

Fitzsimons TC, Lewis JM, Wright A, Kleifeld O, Schittenhelm RB, Powell D, Harper M, Boyce JD.

Infect Immun. 2018 Jul 23;86(8). pii: e00297-18. doi: 10.1128/IAI.00297-18. Print 2018 Aug.

4.

Emergence of High-Level Colistin Resistance in an Acinetobacter baumannii Clinical Isolate Mediated by Inactivation of the Global Regulator H-NS.

Deveson Lucas D, Crane B, Wright A, Han ML, Moffatt J, Bulach D, Gladman SL, Powell D, Aranda J, Seemann T, Machado D, Pacheco T, Marques T, Viveiros M, Nation R, Li J, Harper M, Boyce JD.

Antimicrob Agents Chemother. 2018 Jun 26;62(7). pii: e02442-17. doi: 10.1128/AAC.02442-17. Print 2018 Jul.

5.

Determination of the small RNA GcvB regulon in the Gram-negative bacterial pathogen Pasteurella multocida and identification of the GcvB seed binding region.

Gulliver EL, Wright A, Lucas DD, Mégroz M, Kleifeld O, Schittenhelm RB, Powell DR, Seemann T, Bulitta JB, Harper M, Boyce JD.

RNA. 2018 May;24(5):704-720. doi: 10.1261/rna.063248.117. Epub 2018 Feb 12.

PMID:
29440476
6.

Optimization of a Meropenem-Tobramycin Combination Dosage Regimen against Hypermutable and Nonhypermutable Pseudomonas aeruginosa via Mechanism-Based Modeling and the Hollow-Fiber Infection Model.

Landersdorfer CB, Rees VE, Yadav R, Rogers KE, Kim TH, Bergen PJ, Cheah SE, Boyce JD, Peleg AY, Oliver A, Shin BS, Nation RL, Bulitta JB.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02055-17. doi: 10.1128/AAC.02055-17. Print 2018 Apr.

7.

Combating Carbapenem-Resistant Acinetobacter baumannii by an Optimized Imipenem-plus-Tobramycin Dosage Regimen: Prospective Validation via Hollow-Fiber Infection and Mathematical Modeling.

Landersdorfer CB, Yadav R, Rogers KE, Kim TH, Shin BS, Boyce JD, Nation RL, Bulitta JB.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02053-17. doi: 10.1128/AAC.02053-17. Print 2018 Apr.

8.

Characterization of Two Novel Lipopolysaccharide Phosphoethanolamine Transferases in Pasteurella multocida and Their Role in Resistance to Cathelicidin-2.

Harper M, Wright A, St Michael F, Li J, Deveson Lucas D, Ford M, Adler B, Cox AD, Boyce JD.

Infect Immun. 2017 Oct 18;85(11). pii: e00557-17. doi: 10.1128/IAI.00557-17. Print 2017 Nov.

9.

The Myriad Properties of Pasteurella multocida Lipopolysaccharide.

Harper M, Boyce JD.

Toxins (Basel). 2017 Aug 21;9(8). pii: E254. doi: 10.3390/toxins9080254. Review.

10.

Global Gene Expression Profile of Acinetobacter baumannii During Bacteremia.

Murray GL, Tsyganov K, Kostoulias XP, Bulach DM, Powell D, Creek DJ, Boyce JD, Paulsen IT, Peleg AY.

J Infect Dis. 2017 Feb 15;215(suppl_1):S52-S57. doi: 10.1093/infdis/jiw529.

PMID:
28375520
11.

RNA-seq analysis of virR and revR mutants of Clostridium perfringens.

Low LY, Harrison PF, Lin YH, Boyce JD, Rood JI, Cheung JK.

BMC Genomics. 2016 May 23;17:391. doi: 10.1186/s12864-016-2706-2.

12.

Polymyxin Resistance in Acinetobacter baumannii: Genetic Mutations and Transcriptomic Changes in Response to Clinically Relevant Dosage Regimens.

Cheah SE, Johnson MD, Zhu Y, Tsuji BT, Forrest A, Bulitta JB, Boyce JD, Nation RL, Li J.

Sci Rep. 2016 May 19;6:26233. doi: 10.1038/srep26233.

13.

Perturbation of the two-component signal transduction system, BprRS, results in attenuated virulence and motility defects in Burkholderia pseudomallei.

Lazar Adler NR, Allwood EM, Deveson Lucas D, Harrison P, Watts S, Dimitropoulos A, Treerat P, Alwis P, Devenish RJ, Prescott M, Govan B, Adler B, Harper M, Boyce JD.

BMC Genomics. 2016 May 4;17:331. doi: 10.1186/s12864-016-2668-4.

14.

Global metabolic analyses identify key differences in metabolite levels between polymyxin-susceptible and polymyxin-resistant Acinetobacter baumannii.

Maifiah MH, Cheah SE, Johnson MD, Han ML, Boyce JD, Thamlikitkul V, Forrest A, Kaye KS, Hertzog P, Purcell AW, Song J, Velkov T, Creek DJ, Li J.

Sci Rep. 2016 Feb 29;6:22287. doi: 10.1038/srep22287.

15.

Protective efficacy afforded by live Pasteurella multocida vaccines in chickens is independent of lipopolysaccharide outer core structure.

Harper M, John M, Edmunds M, Wright A, Ford M, Turni C, Blackall PJ, Cox A, Adler B, Boyce JD.

Vaccine. 2016 Mar 29;34(14):1696-703. doi: 10.1016/j.vaccine.2016.02.017. Epub 2016 Feb 16.

PMID:
26892738
16.

The RNA-Binding Chaperone Hfq Is an Important Global Regulator of Gene Expression in Pasteurella multocida and Plays a Crucial Role in Production of a Number of Virulence Factors, Including Hyaluronic Acid Capsule.

Mégroz M, Kleifeld O, Wright A, Powell D, Harrison P, Adler B, Harper M, Boyce JD.

Infect Immun. 2016 Apr 22;84(5):1361-1370. doi: 10.1128/IAI.00122-16. Print 2016 May.

17.

The Burkholderia pseudomallei Proteins BapA and BapC Are Secreted TTSS3 Effectors and BapB Levels Modulate Expression of BopE.

Treerat P, Alwis P, D'Cruze T, Cullinane M, Vadivelu J, Devenish RJ, Prescott M, Adler B, Boyce JD.

PLoS One. 2015 Dec 1;10(12):e0143916. doi: 10.1371/journal.pone.0143916. eCollection 2015.

18.

Comparative Genomic Analysis of Asian Haemorrhagic Septicaemia-Associated Strains of Pasteurella multocida Identifies More than 90 Haemorrhagic Septicaemia-Specific Genes.

Moustafa AM, Seemann T, Gladman S, Adler B, Harper M, Boyce JD, Bennett MD.

PLoS One. 2015 Jul 7;10(7):e0130296. doi: 10.1371/journal.pone.0130296. eCollection 2015.

19.

Novel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumannii.

Yadav R, Landersdorfer CB, Nation RL, Boyce JD, Bulitta JB.

Antimicrob Agents Chemother. 2015 Apr;59(4):2286-98. doi: 10.1128/AAC.04379-14. Epub 2015 Feb 2.

20.

Burkholderia pseudomallei type III secretion system cluster 3 ATPase BsaS, a chemotherapeutic target for small-molecule ATPase inhibitors.

Gong L, Lai SC, Treerat P, Prescott M, Adler B, Boyce JD, Devenish RJ.

Infect Immun. 2015 Apr;83(4):1276-85. doi: 10.1128/IAI.03070-14. Epub 2015 Jan 20.

21.

The transcriptomic response of Acinetobacter baumannii to colistin and doripenem alone and in combination in an in vitro pharmacokinetics/pharmacodynamics model.

Henry R, Crane B, Powell D, Deveson Lucas D, Li Z, Aranda J, Harrison P, Nation RL, Adler B, Harper M, Boyce JD, Li J.

J Antimicrob Chemother. 2015 May;70(5):1303-13. doi: 10.1093/jac/dku536. Epub 2015 Jan 14.

22.

Development of a rapid multiplex PCR assay to genotype Pasteurella multocida strains by use of the lipopolysaccharide outer core biosynthesis locus.

Harper M, John M, Turni C, Edmunds M, St Michael F, Adler B, Blackall PJ, Cox AD, Boyce JD.

J Clin Microbiol. 2015 Feb;53(2):477-85. doi: 10.1128/JCM.02824-14. Epub 2014 Nov 26.

23.

Characterization of the lipopolysaccharide produced by Pasteurella multocida serovars 6, 7 and 16: identification of lipopolysaccharide genotypes L4 and L8.

Harper M, St Michael F, Steen JA, John M, Wright A, van Dorsten L, Vinogradov E, Adler B, Cox AD, Boyce JD.

Glycobiology. 2015 Mar;25(3):294-302. doi: 10.1093/glycob/cwu110. Epub 2014 Oct 7.

PMID:
25298538
24.

Genomic evidence for a globally distributed, bimodal population in the ovine footrot pathogen Dichelobacter nodosus.

Kennan RM, Gilhuus M, Frosth S, Seemann T, Dhungyel OP, Whittington RJ, Boyce JD, Powell DR, Aspán A, Jørgensen HJ, Bulach DM, Rood JI.

MBio. 2014 Sep 30;5(5):e01821-14. doi: 10.1128/mBio.01821-14.

25.

In silico prediction of Gallibacterium anatis pan-immunogens.

Bager RJ, Kudirkiene E, da Piedade I, Seemann T, Nielsen TK, Pors SE, Mattsson AH, Boyce JD, Adler B, Bojesen AM.

Vet Res. 2014 Aug 8;45:80. doi: 10.1186/s13567-014-0080-0.

26.

Structural analysis of lipopolysaccharide produced by Heddleston serovars 10, 11, 12 and 15 and the identification of a new Pasteurella multocida lipopolysaccharide outer core biosynthesis locus, L6.

Harper M, St Michael F, John M, Steen J, van Dorsten L, Parnas H, Vinogradov E, Adler B, Cox AD, Boyce JD.

Glycobiology. 2014 Jul;24(7):649-59. doi: 10.1093/glycob/cwu030. Epub 2014 Apr 16.

PMID:
24740556
27.

Biological cost of different mechanisms of colistin resistance and their impact on virulence in Acinetobacter baumannii.

Beceiro A, Moreno A, Fernández N, Vallejo JA, Aranda J, Adler B, Harper M, Boyce JD, Bou G.

Antimicrob Agents Chemother. 2014;58(1):518-26. doi: 10.1128/AAC.01597-13. Epub 2013 Nov 4.

28.

Identification of a DNA-damage-inducible regulon in Acinetobacter baumannii.

Aranda J, Poza M, Shingu-Vázquez M, Cortés P, Boyce JD, Adler B, Barbé J, Bou G.

J Bacteriol. 2013 Dec;195(24):5577-82. doi: 10.1128/JB.00853-13. Epub 2013 Oct 11.

29.

Evolutionary analysis of Burkholderia pseudomallei identifies putative novel virulence genes, including a microbial regulator of host cell autophagy.

Singh AP, Lai SC, Nandi T, Chua HH, Ooi WF, Ong C, Boyce JD, Adler B, Devenish RJ, Tan P.

J Bacteriol. 2013 Dec;195(24):5487-98. doi: 10.1128/JB.00718-13. Epub 2013 Oct 4.

30.

Pasteurella multocida Heddleston serovar 3 and 4 strains share a common lipopolysaccharide biosynthesis locus but display both inter- and intrastrain lipopolysaccharide heterogeneity.

Harper M, St Michael F, John M, Vinogradov E, Steen JA, van Dorsten L, Steen JA, Turni C, Blackall PJ, Adler B, Cox AD, Boyce JD.

J Bacteriol. 2013 Nov;195(21):4854-64. doi: 10.1128/JB.00779-13. Epub 2013 Aug 23.

31.

The fimbrial protein FlfA from Gallibacterium anatis is a virulence factor and vaccine candidate.

Bager RJ, Nesta B, Pors SE, Soriani M, Serino L, Boyce JD, Adler B, Bojesen AM.

Infect Immun. 2013 Jun;81(6):1964-73. doi: 10.1128/IAI.00059-13. Epub 2013 Mar 18.

32.

Lipopolysaccharide-deficient Acinetobacter baumannii shows altered signaling through host Toll-like receptors and increased susceptibility to the host antimicrobial peptide LL-37.

Moffatt JH, Harper M, Mansell A, Crane B, Fitzsimons TC, Nation RL, Li J, Adler B, Boyce JD.

Infect Immun. 2013 Mar;81(3):684-9. doi: 10.1128/IAI.01362-12. Epub 2012 Dec 17.

33.

Structure and biosynthetic locus of the lipopolysaccharide outer core produced by Pasteurella multocida serovars 8 and 13 and the identification of a novel phospho-glycero moiety.

Harper M, St Michael F, Vinogradov E, John M, Steen JA, van Dorsten L, Boyce JD, Adler B, Cox AD.

Glycobiology. 2013 Mar;23(3):286-94. doi: 10.1093/glycob/cws154. Epub 2012 Oct 31.

PMID:
23118207
34.

Beclin 1 is required for starvation-enhanced, but not rapamycin-enhanced, LC3-associated phagocytosis of Burkholderia pseudomallei in RAW 264.7 cells.

Li X, Prescott M, Adler B, Boyce JD, Devenish RJ.

Infect Immun. 2013 Jan;81(1):271-7. doi: 10.1128/IAI.00834-12. Epub 2012 Oct 31.

35.

Screening of 71 P. multocida proteins for protective efficacy in a fowl cholera infection model and characterization of the protective antigen PlpE.

Hatfaludi T, Al-Hasani K, Gong L, Boyce JD, Ford M, Wilkie IW, Quinsey N, Dunstone MA, Hoke DE, Adler B.

PLoS One. 2012;7(7):e39973. doi: 10.1371/journal.pone.0039973. Epub 2012 Jul 5.

36.

Pasteurella multocida: diseases and pathogenesis.

Wilkie IW, Harper M, Boyce JD, Adler B.

Curr Top Microbiol Immunol. 2012;361:1-22. doi: 10.1007/82_2012_216. Review.

PMID:
22643916
37.

Natural transformation of Gallibacterium anatis.

Kristensen BM, Sinha S, Boyce JD, Bojesen AM, Mell JC, Redfield RJ.

Appl Environ Microbiol. 2012 Jul;78(14):4914-22. doi: 10.1128/AEM.00412-12. Epub 2012 May 11.

38.

Cell surface hydrophobicity of colistin-susceptible vs resistant Acinetobacter baumannii determined by contact angles: methodological considerations and implications.

Soon RL, Li J, Boyce JD, Harper M, Adler B, Larson I, Nation RL.

J Appl Microbiol. 2012 Oct;113(4):940-51. doi: 10.1111/j.1365-2672.2012.05337.x.

39.

Pathogenomics of Pasteurella multocida.

Boyce JD, Seemann T, Adler B, Harper M.

Curr Top Microbiol Immunol. 2012;361:23-38. doi: 10.1007/82_2012_203. Review.

PMID:
22402726
40.

The key surface components of Pasteurella multocida: capsule and lipopolysaccharide.

Harper M, Boyce JD, Adler B.

Curr Top Microbiol Immunol. 2012;361:39-51. doi: 10.1007/82_2012_202. Review.

PMID:
22373812
41.

Colistin-resistant, lipopolysaccharide-deficient Acinetobacter baumannii responds to lipopolysaccharide loss through increased expression of genes involved in the synthesis and transport of lipoproteins, phospholipids, and poly-β-1,6-N-acetylglucosamine.

Henry R, Vithanage N, Harrison P, Seemann T, Coutts S, Moffatt JH, Nation RL, Li J, Harper M, Adler B, Boyce JD.

Antimicrob Agents Chemother. 2012 Jan;56(1):59-69. doi: 10.1128/AAC.05191-11. Epub 2011 Oct 24.

42.

Strategies for Intracellular Survival of Burkholderia pseudomallei.

Allwood EM, Devenish RJ, Prescott M, Adler B, Boyce JD.

Front Microbiol. 2011 Aug 22;2:170. doi: 10.3389/fmicb.2011.00170. eCollection 2011.

43.

Characterization of the lipopolysaccharide from Pasteurella multocida Heddleston serovar 9: identification of a proposed bi-functional dTDP-3-acetamido-3,6-dideoxy-α-D-glucose biosynthesis enzyme.

Harper M, St Michael F, Vinogradov E, John M, Boyce JD, Adler B, Cox AD.

Glycobiology. 2012 Mar;22(3):332-44. doi: 10.1093/glycob/cwr147. Epub 2011 Oct 15.

PMID:
22002973
44.

Necrotic enteritis-derived Clostridium perfringens strain with three closely related independently conjugative toxin and antibiotic resistance plasmids.

Bannam TL, Yan XX, Harrison PF, Seemann T, Keyburn AL, Stubenrauch C, Weeramantri LH, Cheung JK, McClane BA, Boyce JD, Moore RJ, Rood JI.

MBio. 2011 Sep 27;2(5). pii: e00190-11. doi: 10.1128/mBio.00190-11. Print 2011.

45.

Effect of colistin exposure and growth phase on the surface properties of live Acinetobacter baumannii cells examined by atomic force microscopy.

Soon RL, Nation RL, Harper M, Adler B, Boyce JD, Tan CH, Li J, Larson I.

Int J Antimicrob Agents. 2011 Dec;38(6):493-501. doi: 10.1016/j.ijantimicag.2011.07.014. Epub 2011 Sep 16.

46.

Role for the Burkholderia pseudomallei type three secretion system cluster 1 bpscN gene in virulence.

D'Cruze T, Gong L, Treerat P, Ramm G, Boyce JD, Prescott M, Adler B, Devenish RJ.

Infect Immun. 2011 Sep;79(9):3659-64. doi: 10.1128/IAI.01351-10. Epub 2011 Jul 18.

47.

Pasteurella multocida lipopolysaccharide: the long and the short of it.

Harper M, Cox AD, Adler B, Boyce JD.

Vet Microbiol. 2011 Nov 21;153(1-2):109-15. doi: 10.1016/j.vetmic.2011.05.022. Epub 2011 May 19. Review.

PMID:
21664074
48.

The Burkholderia pseudomallei type III secretion system and BopA are required for evasion of LC3-associated phagocytosis.

Gong L, Cullinane M, Treerat P, Ramm G, Prescott M, Adler B, Boyce JD, Devenish RJ.

PLoS One. 2011 Mar 11;6(3):e17852. doi: 10.1371/journal.pone.0017852.

49.

Insertion sequence ISAba11 is involved in colistin resistance and loss of lipopolysaccharide in Acinetobacter baumannii.

Moffatt JH, Harper M, Adler B, Nation RL, Li J, Boyce JD.

Antimicrob Agents Chemother. 2011 Jun;55(6):3022-4. doi: 10.1128/AAC.01732-10. Epub 2011 Mar 14.

50.

Pasteurella multocida Heddleston serovars 1 and 14 express different lipopolysaccharide structures but share the same lipopolysaccharide biosynthesis outer core locus.

Harper M, St Michael F, John M, Vinogradov E, Adler B, Boyce JD, Cox AD.

Vet Microbiol. 2011 Jun 2;150(3-4):289-96. doi: 10.1016/j.vetmic.2011.01.028. Epub 2011 Mar 3.

PMID:
21371830

Supplemental Content

Loading ...
Support Center